We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
Cap. Flow
-$2.97B
Cap. Flow %
-3.9%
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$77.3M
2
BX icon
Blackstone
BX
+$53.2M
3
NXPI icon
NXP Semiconductors
NXPI
+$40.8M
4
PLTR icon
Palantir
PLTR
+$34.3M
5
SNOW icon
Snowflake
SNOW
+$24.8M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$206M
2
MSFT icon
Microsoft
MSFT
+$163M
3
LIN icon
Linde
LIN
+$133M
4
AMZN icon
Amazon
AMZN
+$94.7M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$82.6M

Sector Composition

Rank Sector Weight
1 Technology 23.34%
2 Financials 14.16%
3 Healthcare 12.95%
4 Consumer Discretionary 12.06%
5 Communication Services 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DEA
1326
Easterly Government Properties
DEA
$1.18B
$6.03M 0.01%
114,378
+16,445
+17% +$869K
LNTH icon
1327
Lantheus
LNTH
$6.6B
$6.02M 0.01%
217,641
+14,541
+7% +$334K
MRTX
1328
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$6.01M 0.01%
37,209
-11,934
-24% -$1.92M
HSKA
1329
DELISTED
Heska Corp
HSKA
$6M 0.01%
26,130
-1,062
-4% -$208K
BHVN
1330
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$5.99M 0.01%
61,738
+9,861
+19% +$800K
KN icon
1331
Knowles
KN
$3.36B
$5.99M 0.01%
303,497
-5,577
-2% -$114K
TRMK icon
1332
Trustmark
TRMK
$2.79B
$5.98M 0.01%
194,151
-8,369
-4% -$276K
NVRO
1333
DELISTED
NEVRO CORP.
NVRO
$5.97M 0.01%
35,986
-1,567
-4% -$245K
FSLY icon
1334
Fastly Inc
FSLY
$3.55B
$5.96M 0.01%
100,034
+22,513
+29% +$1.28M
MCY icon
1335
Mercury Insurance
MCY
$5.95B
$5.95M 0.01%
91,581
+16,113
+21% +$1.02M
HNI icon
1336
HNI Corp
HNI
$3.53B
$5.94M 0.01%
135,095
-6,754
-5% -$293K
SPCE icon
1337
Virgin Galactic
SPCE
$377M
$5.93M 0.01%
6,444
+2,921
+83% +$1.66M
MHO icon
1338
M/I Homes
MHO
$3.71B
$5.92M 0.01%
100,985
-4,022
-4% -$260K
CENTA icon
1339
Central Garden & Pet Co Class A
CENTA
$2.54B
$5.92M 0.01%
153,268
-4,800
-3% -$197K
HASI icon
1340
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.89B
$5.91M 0.01%
105,172
-7,476
-7% -$389K
SBCF icon
1341
Seacoast Banking Corp of Florida
SBCF
$3.34B
$5.9M 0.01%
172,715
-7,043
-4% -$257K
PRGS icon
1342
Progress Software
PRGS
$1.71B
$5.9M 0.01%
127,479
-985
-0.8% -$44.6K
COKE icon
1343
Coca-Cola Consolidated
COKE
$12.5B
$5.87M 0.01%
146,010
-5,080
-3% -$179K
EGBN icon
1344
Eagle Bancorp
EGBN
$849M
$5.86M 0.01%
104,491
-5,659
-5% -$313K
RAVN
1345
DELISTED
Raven Industries Inc
RAVN
$5.85M 0.01%
101,156
-17,282
-15% -$752K
LTC
1346
LTC Properties
LTC
$2.02B
$5.82M 0.01%
151,590
+793
+0.5% +$32.3K
ILPT
1347
Industrial Logistics Properties Trust
ILPT
$575M
$5.8M 0.01%
221,984
-11,967
-5% -$301K
ARNA
1348
DELISTED
Arena Pharmaceuticals Inc
ARNA
$5.8M 0.01%
85,009
-4,689
-5% -$306K
APPN icon
1349
Appian
APPN
$2.23B
$5.79M 0.01%
42,018
+1,865
+5% +$212K
STRA icon
1350
Strategic Education
STRA
$1.86B
$5.78M 0.01%
75,989
+9,348
+14% +$746K

Similar funds

RhumbLine Advisers's Q2 2021 Portfolio in Review

As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.

  • RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
  • RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
  • RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
  • RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
  • RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
  • RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.

Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.